Galmed Pharmaceuticals (EOCN) Non-Current Assets (2013 - 2026)
Galmed Pharmaceuticals' Non-Current Assets came in at $6.57 million for Q2 2026, up 253.2% from $1.86 million a year earlier.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Galmed Pharmaceuticals' Non-Current Assets was $262,000, up 8.3% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of -14.4% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $242,000 in FY2024 (-92.9%), $3.39 million in FY2023 (+84.5%), $1.84 million in FY2022 (+233.4%) and $551,000 in FY2021 (-3.3%).
- The Q2 2026 figure represents the highest quarterly Non-Current Assets in data going back to Q4 2013.
- Year-over-year, Non-Current Assets increased in two of the last seven quarters, with growth averaging 7.0%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q3 2023 (growth of 779.8%), and the weakest in Q4 2024 (a decline of 92.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Galmed Pharmaceuticals | 1.64 Mn | -39.05 Mn | - | 6.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.57 Mn |
| Dec 31, 2025 | 262,000.00 |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | 2.38 Mn |
| Sep 30, 2024 | 3.27 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 3.39 Mn |
| Sep 30, 2023 | 3.44 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 391,000.00 |
| Jun 30, 2022 | 445,000.00 |
| Mar 31, 2022 | 497,000.00 |
| Dec 31, 2021 | 551,000.00 |
| Sep 30, 2021 | 606,000.00 |
| Jun 30, 2021 | 660,000.00 |
API Access
Galmed Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();